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PERSPECTIVE
LINking microRNAs, kidney
development, and Wilms tumors
Peter Hohenstein1,2,3 and Nicholas D. Hastie2
1The Roslin Institute, University of Edinburgh, Midlothian EH23 4RB, United Kingdom; 2MRC Human Genetics Unit, MRC
Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU,
United Kingdom
In this issue of Genes & Development, Urbach and col-
leagues (pp. 971–982) provide compelling data suggesting
a role for LIN28 in the pathogenesis of a significant per-
centage of Wilms tumors. These data extend our insights
in the genetics underlying Wilms tumor development and
emphasize the importance of stemness and microRNA-
mediated processes in the origins of these tumors.
Wilms tumors are pediatric cancers affecting one in
10,000 children. They are the result of normal kidney
development going awry, possibly around the mesenchy-
mal-to-epithelial transition (MET) stage at the onset of
nephrogenesis. Histological and transcriptomic analyses of
Wilms tumors have shown them to be a heterogeneous
group of tumors that could originate from different de-
velopmental stages (Gadd et al. 2012). Mutations in
different genes have been implicated as the driving force
of these tumors, including the loss ofWT1 andWTX and
the activation of IGF2 and CTNNB1 (the gene encoding
b-catenin). Of these, WT1 and CTNNB1 have been func-
tionally linked to early kidney development and regulation
of the progenitor cells undergoing the MET (Essafi et al.
2011; Park et al. 2012). The functional rationale for
perturbations in WTX and IGF2 is less clear, although
tumor analyses have clearly shown involvement at some
stage of the tumorigenic process.
Urbach et al. (2014) now add the LIN28 genes to this
group of Wilms tumor genes. Using doxycycline-induc-
ible mouse models for overexpression of Lin28a and
LIN28B, the investigators showed that activation of
either gene results in the formation of Wilms tumors
through either leaky expression of Lin28a in a Vasa-Cre-
driven system or the directed expression of LIN28B in the
renalWt1 lineage. The primary phenotype in the kidneys
of these animals was a prolonged proliferation of the Six2+
nephron progenitor cells that form the cap mesenchyme
(Kobayashi et al. 2008). In wild-type animals, these cells
undergo a final, synchronized differentiation a few days
after birth. In mutant mice, they remained present as long
as LIN28 expression was induced; it took several weeks
after LIN28 withdrawal for the cells to finally undergo
terminal differentiation. Unexpectedly—but consistent
with this observation—the mutant cells were even able
to epithelialize and form glomeruli in the presence of
LIN28 overexpression. Therefore, a disturbance in the
balance between proliferation and differentiation of these
cells—rather than a differentiation block—seems to be the
cause of these tumors.
The origin of the tumors in these models is not com-
pletely clear. Activation of a Wt1-Cre allele from as early
as the onset of intermediate mesoderm formation—and
therefore in the earliest precursor of the complete meta-
nephric kidney—did drive tumorigenesis. However, re-
stricted activation in the nephron progenitors (via Six2-
driven Cre), the stromal cells (Foxd1-Cre), or collecting
duct (Cdh16-Cre) did not. We can thus conclude that
either the transgenes need to be induced at a very early
stage of kidney development or activation in multiple
lineages is required. It is difficult to conclusively prove one
or the other option using the current models
Wilms tumor cancer stem cells (CSCs) have recently
been identified as NCAM1+ALDH1+ cells (Pode-Shakked
et al. 2013). The clinical relevance of the LIN28 mouse
models is underscored by the observation of increased
LIN28B (but not LIN28A) expression in 18 of 105 Wilms
tumor samples and CSCs. LIN28B expression was local-
ized to the blastemal component, and a strong correlation
was found between LIN28B expression, tumor relapse,
and mortality. Although both LIN28A and LIN28B could
induce tumor formation in mouse models, only LIN28B
activation was observed in patient samples. This sur-
prising observation could be explained through an un-
known mechanism that drives the specific activation of
the LIN28B locus.
Both LIN28 paralogs are known to have important and
evolutionarily conserved roles in stemness (Shyh-Chang
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and Daley 2013). Lin28a is highly expressed in mouse
embryonic stem cells and, together with Oct4, Sox2, and
Nanog, can reprogram somatic cells into induced plurip-
otent stem cells (iPSCs). Both Lin28a and Lin28b function
through two different mechanisms: They can bind a wide
variety of mRNAs to regulate their translation and can
recruit terminal uridylyl transferases to inhibit the mat-
uration of let-7 microRNAs (miRNAs). Uridylated pre-
let-7 cannot be processed by DICER into a mature
miRNA and is therefore broken down by a nuclease. Via
either route, LIN28 is directly involved in known meta-
bolic and oncogenic pathways. To elucidate the mecha-
nism bywhich LIN28 inducesWilms tumors, Urbach et al.
(2014) crossed their tumor-prone mice with a model that
expresses a LIN28-independent form of let-7 and found
a complete rescue of the phenotype. Consistently, a dra-
matic increase in the expression of known let-7 targets
was found in LIN28-induced tumors. Although this does
not exclude a role for the mRNA-binding activity of
LIN28, it is clear that let-7 suppression is essential for
Wilms tumorigenesis in these models.
This study adds to an increasing amount of data impli-
cating miRNAs in Wilms tumor development. In rare
cases, translocation-mediated activation of LIN28B has
been observed in Wilms tumors (Viswanathan et al. 2009),
as has loss ofDICER1 (Wu et al. 2013). Perlman syndrome,
which is characterized by fetal overgrowth and a predispo-
sition to Wilms tumors, is caused by loss of the gene
encodingDIS3L2, the 39–59 exonuclease that degrades pre-
let-7 after LIN28-mediated uridylation (Chang et al. 2013).
Disruptions in miRNA expression and processing could be
an important player inWilms tumorigenesis, and on-going
Wilms tumor genome sequencing projects will hopefully
shed more light on this.
If the disruption of miRNA pathways can lead to the
formation of Wilms tumors, which are thought to be
the direct result of disturbed embryonic kidney develop-
ment, one would expect an essential role for miRNAs in
normal kidney development, in particular in the processes
impaired in Wilms tumor formation. Indeed, conditional
loss of Dicer in different renal lineages and in different
developmental stages results in severe phenotypes
(Nagalakshmi et al. 2011; Chu et al. 2014). A careful
analysis of changes in miRNA expression patterns in
Wilms tumor samples and comparison with the normal
cell type-specific expression pattern of miRNAs in the
developing kidney may identify new players, pathways,
and therapeutic targets.
The roles of LIN28 in stemness and oncogenesis (Shyh-
Chang andDaley 2013) raise the possibility of a functional
role for Lin28 in Wilms tumor CSCs. As mentioned
before, these cells are characterized by NCAM1 expres-
sion and ALDH1 activity. When these CSCs were first
identified, it was noted that in normal kidney develop-
ment, these two markers are not found in the same cell
types, and it was suggested that NCAM1 acts as amarker
for the developmental stage of origin, while ALDH1
activity was linked to the oncogenic characteristics of
the cells (Pode-Shakked et al. 2013). Somehow, these
two markers need to become expressed in the same cell.
Is it possible that LIN28 plays an active role in this?
Urbach et al. (2014) show that the NCAM1+ ALDH1+
population expresses high levels of LIN28B. In breast
cancer CSCs, the LIN28/let-7 pathway has been sug-
gested to have a stimulating effect on the maintenance
ALDH1+ cells (Yang et al. 2010). Another recent study
demonstrated that premature termination of in vivo iPSC
reprogramming, a process in which Lin28a can function
as well, results in tumors resembling Wilms tumors
(Ohnishi et al. 2014). These tumors could form secondary
tumors through transplantation even after the induction
of the reprogramming factors was lost. This could suggest
that some CSC phenotype had been induced, although
NCAM1 and ALDH1 were not analyzed. It would be
interesting to see whether activation of LIN28 in the
mice generated by Urbach et al. (2014) would directly
result in the appearance of NCAM1+ ALDH1+ Wilms
tumor CSCs and whether passaging of these tumors in
immunocompromised mice is also possible in the ab-
sence of LIN28 induction, as is the case for the iPSC
factor-induced tumors.
The identification of a role for LIN28 in driving Wilms
tumor will likely affect many different aspects of Wilms
tumor biology and normal kidney development and
emphasizes the importance of studying these two sides
of the same coin in a combined manner.
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